Cargando…
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or early discontinuation. We aim to estimate the effects of hydroxychloroquine and chloroquine on survival in COVID-19 from...
Ejemplares similares
-
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
por: Axfors, Cathrine, et al.
Publicado: (2021) -
Subclinical Myocardial Injury and Risk of COVID-19 in the General Population: The Trøndelag Health Study
por: Lyngbakken, Magnus Nakrem, et al.
Publicado: (2021) -
Tobacco Consumption and High‐Sensitivity Cardiac Troponin I in the General Population: The HUNT Study
por: Skranes, Julia Brox, et al.
Publicado: (2022) -
Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic
por: Janiaud, Perrine, et al.
Publicado: (2021) -
Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea
por: Berge, Kristian, et al.
Publicado: (2022)